Showing results (1-10 of 299) with videos related to
Sort By:
Pageof 30
Current Opinion in Lipidology|December 15, 2015
Apolipoprotein A-I interactions with insulin secretion and productionKerry-Anne Rye, Philip J Barter, Blake J CochranAtherosclerosis|October 3, 2018
CETP inhibition, statins and diabetesPhilip J Barter, Blake J Cochran, Kerry-Anne RyeJournal of Lipid Research|May 3, 2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular riskPhilip J Barter, Kerry-Anne RyeCirculation Research|January 4, 2014
Regulation of high-density lipoprotein metabolismKerry-Anne Rye, Philip J BarterArteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2003
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-IKerry-Anne Rye, Philip J BarterArteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2007
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?Philip J Barter, Kerry-Anne RyePharmacological Reviews|March 18, 2016
New Era of Lipid-Lowering DrugsPhilip J Barter, Kerry-Anne RyeCardiology Clinics|April 4, 2018
Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease RiskPhilip J Barter, Kerry-Anne RyeJournal of Lipid Research|July 2, 2013
Cardioprotective functions of HDLsKerry-Anne Rye, Philip J BarterBiochimica Et Biophysica Acta|November 5, 2011
Predictive value of different HDL particles for the protection against or risk of coronary heart diseaseKerry-Anne Rye, Philip J BarterPageof 30